Endothelial MicroRNA-214 Confers Angiotensin II Hypertension by Targeting eNOS in Mice
Kidney and Blood Pressure Research · 2025
DOI: 10.1159/000546674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2025. Verfasst von Shuzhen Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: MicroRNAs, Angiotensin II, Hypertension, Nitric Oxide Synthase Type III. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
MicroRNAs have been increasingly recognized for their roles in cardiovascular diseases. Among these microRNAs, miR-214 was reported to be involved in hypertension. However, the role of endothelial miR-214 in hypertension is still unknown. The aim of this study was to determine the role of cell-specific miR-214 on regulating blood pressure, as well as the potential mechanisms.
Methods
We detected the levels of miR-214 in hypertensive mice and cultured mouse aortic endothelial cells (MAECs). In addition, mouse miR-214 inhibitor, miR-214 mimics, vascular endothelial cell-specific miR-214-deficient mice, smooth muscle cell-specific miR-214-deficient mice, renal proximal tubule cell-deficient mice, and various cellular and molecular techniques were employed to define the role of miR-214 in Ang II-induced hypertension.
Results
In mice and MAECs, Ang II significantly enhanced miR-214 levels, and anti-miR-214 markedly attenuated Ang II hypertension in line with enhanced eNOS/p-eNOS in aorta. Then, we generated vascular endothelial cell-specific miR-214 knockout mice and found an antihypertensive phenotype in endothelial miR-214 conditional knockout mice after Ang II treatment. In normotensive animals and MAECs, exogenous miR-214 administration reduced eNOS expression at protein and mRNA levels; in contrast, anti-miR-214 played an opposite role in regulating eNOS. By luciferase assay, our results confirmed that eNOS was a direct target gene for miR-214 in endothelial cells. However, smooth muscle cell-specific or renal tubular cell-specific deletion of miR-214 did not alter Ang II-induced hypertension.
Conclusion
Our findings suggested that endothelial miR-214 promoted Ang II hypertension by targeting eNOS in mice, which increased the understanding on the pathogenic mechanism of hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
- Jiangsu Key Laboratory of Early Development and Chronic Diseases Prevention in Children, Nanjing Medical University, Nanjing, China.
- Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
Zitieren
APA
Li, S., Liu, B., Kang, S., Yang, B., Zhang, Y., Huang, S., Zhang, A., & Jia, Z. (2025). Endothelial MicroRNA-214 Confers Angiotensin II Hypertension by Targeting eNOS in Mice. Kidney and Blood Pressure Research. https://doi.org/10.1159/000546674
Vancouver
Li S, Liu B, Kang S, Yang B, Zhang Y, Huang S, et al. Endothelial MicroRNA-214 Confers Angiotensin II Hypertension by Targeting eNOS in Mice. Kidney and Blood Pressure Research. 2025. doi:10.1159/000546674
BibTeX
@article{Li2025,
author = {Li, Shuzhen and Liu, Bing and Kang, Shuang and Yang, Bingyu and Zhang, Yue and Huang, Songming and Zhang, Aihua and Jia, Zhanjun},
title = {Endothelial MicroRNA-214 Confers Angiotensin II Hypertension by Targeting eNOS in Mice},
journal = {Kidney and Blood Pressure Research},
year = {2025},
doi = {10.1159/000546674}
}
EUVIMED